N. Myakova

发表

Steroid cataract in patients with hemoblastosis

A. Smirnova, B. S. Pershin, N. Myakova, 2019, Pediatric Hematology/Oncology and Immunopathology.

Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations

B. Burkhardt, J. Wachowiak, A. Attarbaschi, 2021, Cancers.

Nodular lymphocyte-predominant Hodgkin Lymphoma in children. Retrospective clinical and morphological analysis of the patients. One Center experience

N. Myakova, D. Konovalov, E. Volchkov, 2021, Pediatric Hematology/Oncology and Immunopathology.

A rare case of nodular lymphocyte predominant Hodgkin lymphoma, which developed 5 years after successful treatment of diffuse large B-cell lymphoma

N. Myakova, A. Rudneva, E. Volchkov, 2021, Pediatric Hematology/Oncology and Immunopathology.

The experience of using the Brentuximab vedotin in the treatment of children and young adults with primary refractory course and relapses of Hodgkin's lymphoma

N. Myakova, A. V. Pshonkin, M. N. Korsantya, 2020, Pediatric Hematology/Oncology and Immunopathology.

Low-intensity therapy cures over 40 % of children with rapid Flow-MRD responding ALL: the ALL-MB 2008 trial results

N. Myakova, G. Tsaur, G. Novichkova, 2022, Pediatric Hematology/Oncology and Immunopathology.

Acute lymphoblastic leukemia in children with Down syndrome: comparative analysis of treatment results according to ALL-MB 2008 and ALL-MB 2015 protocols

N. Myakova, G. Novichkova, A. Popov, 2022, Russian Journal of Pediatric Hematology and Oncology.

High-risk acute lymphoblastic leukemia in the ALL-MB 2002 study

N. Myakova, L. Fechina, G. Novichkova, 2022, Pediatric Hematology/Oncology and Immunopathology.

Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion

Y. Skvortsova, N. Myakova, A. Maschan, 2015, Clinical case reports.

Acute lymphoblastic leukemia with the t(17;19) translocation: hope has appeared! Multimodal immunotherapy in a 3-year-old child with refractory disease: a case report

E. Mikhaylova, N. Myakova, L. Shelikhova, 2022, Pediatric Hematology/Oncology and Immunopathology.

Rituximab and reduced‐intensity chemotherapy in children and adolescents with mature B‐cell lymphoma: interim results for 231 patients enrolled in the second Russian‐Belorussian multicentre study B‐NHL‐2010M

N. Myakova, A. Maschan, N. Ponomareva, 2019, British journal of haematology.

Therapy of Advanced-stage Mature B-cell Lymphoma and Leukemia in Children and Adolescents With Rituximab and Reduced Intensity Induction Chemotherapy (B-NHL 2004M Protocol): The Results of a Multicenter Study

N. Myakova, A. Maschan, L. Shelikhova, 2014, Journal of pediatric hematology/oncology.

Predictive value of metabolic parameters of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography for survival rates of children with lymphoma (a metaanalysis and literature review)

N. Myakova, Y. Likar, M. Yadgarov, 2021, Pediatric Hematology/Oncology and Immunopathology.

Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002

G. Henze, J. Boos, A. von Stackelberg, 2019, Journal of Cancer Research and Clinical Oncology.

Subcutaneous panniculitis‐like T‐cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome

W. Klapper, A. Attarbaschi, U. Kontny, 2015, The British journal of dermatology.

Panniculitis-like T-cell lymphoma in children

N. Myakova, L. Shelihova, D. Abramov, 2019, Pediatric Hematology/Oncology and Immunopathology.

Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy

M. Kazanov, I. Mamedov, N. Myakova, 2022, International journal of molecular sciences.

Features of relapses and refractory forms of T-lymphoblastic lymphoma in children

N. Myakova, Z. Abashidze, U. U. Dyakonova, 2020, Pediatric Hematology/Oncology and Immunopathology.

First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia

N. Myakova, M. Maschan, L. Shelikhova, 2019, Pediatric Hematology/Oncology and Immunopathology.

Prognostic markers of lymphoblastic lymphoma

N. Myakova, Y. Olshanskaya, E. Volchkov, 2020, Pediatric Hematology/Oncology and Immunopathology.

Treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin’s lymphoma (gray zone lymphoma) in children and young adults: a case series

N. Myakova, O. Prudnikova, D. S. Abramov, 2022, Pediatric Hematology/Oncology and Immunopathology.

The evaluation of minimal disseminated disease in the bone marrow of children with Burkitt lymphoma using next generation sequencing

I. Mamedov, N. Myakova, G. Novichkova, 2023, Pediatric Hematology/Oncology and Immunopathology.

Heart failure as a manifestation of acute lymphoblastic leukemia

N. Myakova, E. Tikhomirova, M. Shatsky, 2023, Pediatric Hematology/Oncology and Immunopathology.

Mycosis fungoides in an 11 year-old child: a case report

N. Myakova, D. S. Abramov, A. V. Pshonkin, 2023, Pediatric Hematology/Oncology and Immunopathology.

[Steroid glaucoma in patients with hemoblastosis].

A. Smirnova, B. S. Pershin, N. Myakova, 2023, Vestnik oftalmologii.

Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002

G. Henze, N. Myakova, G. Tallen, 2015, Leukemia.

Prognostic significance of various 11q23/KMT2A rearrangements in infants with acute lymphoblastic leuekemia

N. Myakova, G. Tsaur, A. Popov, 2021 .

The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience

N. Myakova, L. Shelikhova, A. Popov, 2023, Pediatric Hematology/Oncology and Immunopathology.

Rosai–Dorfman disease (sinus histiocytosis with massive lymphadenopathy): personal observations and literature review

N. Myakova, Y. Likar, I. N. Vorozhtsov, 2023, Pediatric Hematology/Oncology and Immunopathology.

Malignant gastrointestinal neuroectodermal tumor

N. Myakova, T. Shamanskaya, D. Kachanov, 2022, Pediatric Hematology/Oncology and Immunopathology.

The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia

N. Myakova, G. Novichkova, L. Shelikhova, 2023, Pediatric Hematology/Oncology and Immunopathology.

Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype

I. Demina, N. Myakova, G. Novichkova, 2019, Journal of Cancer Research and Clinical Oncology.

B-cell lymphoma is unclassifiable, with signs intermediate between diffuse large-cell B-cell lymphoma and Hodgkin lymphoma

A. P. Shcherbakov, N. Myakova, G. Sagoyan, 2019, Pediatric Hematology/Oncology and Immunopathology.

Tcrαβ+/CD19+-Depletion in Hematopoietic Stem Cells Transplantation from Matched Unrelated and Haploidentical Donors Following Treosulfan or TBI-Based Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients

N. Myakova, M. Maschan, G. Novichkova, 2016 .

A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL

N. Myakova, N. Ponomareva, A. Popov, 2023, Cancers.